Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02666222 · ClinicalTrials.gov registry record
The Esteem® Hearing Implant Post Approval Study
A clinical trial, sponsored by Envoy Medical Corporation.
- Completed
- Registry status
- 51
- Enrollment target
NCT02666222: Completed study, sponsored by Envoy Medical Corporation.
NCT02666222 is a clinical trial that has completed, run by Envoy Medical Corporation. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02666222 has completed, sponsored by Envoy Medical Corporation.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and efficacy of the Esteem® Hearing Implant in subjects suffering from moderate to severe hearing loss.
Primary Outcome
ENDPOINT #1: SRT at baseline minus SRT at Year 5. Positive difference (i.e. lower value of SRT with the Esteem) indicates better outcome.
Interventions
- DEVICE The Esteem Hearing Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-03 |
What the finished NCT02666222 record still lists
NCT02666222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which The Esteem Hearing Implant is the first listed.
NCT02666222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02666222 about?
NCT02666222 is a clinical study titled "The Esteem® Hearing Implant Post Approval Study". The purpose of this study is to evaluate the long-term safety and efficacy of the Esteem® Hearing Implant in subjects suffering from moderate to severe hearing loss.
What is the current status of trial NCT02666222?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2010-08. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02666222?
The interventions under investigation include: The Esteem Hearing Implant (DEVICE).
Who is sponsoring clinical trial NCT02666222?
This trial is sponsored by Envoy Medical Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia